2022
Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic
Damast S, Tien CJ, Young M, Altwerger G, Ratner E. Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic. Journal Of Contemporary Brachytherapy 2022, 14: 66-71. PMID: 35233237, PMCID: PMC8867238, DOI: 10.5114/jcb.2022.113058.Peer-Reviewed Original ResearchOverall treatment timeHR-CTV DCervical cancerMucosal toxicityMedian high-risk clinical target volumeHigh-risk clinical target volumeCOVID-19 pandemicLocal control outcomesPre-COVID cohortClinical target volumeMagnetic resonance imagingGastrointestinal eventsRetrospective reviewCC patientsEarly outcomesCOVID groupMedian numberInpatient resourcesInterstitial brachytherapyGrade 2Local controlResonance imagingSeparate weeksTarget volumePatients
2013
SU‐E‐J‐24: Imaging Dose Dependence On Fractionation Scheme and Tracking Method in CyberKnife Robotic Radiosurgery
Tien C, Dieterich S, Lee S, Curran B, Sternick E. SU‐E‐J‐24: Imaging Dose Dependence On Fractionation Scheme and Tracking Method in CyberKnife Robotic Radiosurgery. Medical Physics 2013, 40: 154-154. DOI: 10.1118/1.4814236.Peer-Reviewed Original ResearchTracking methodAmorphous silicon flat-panel detectorRobotic radiosurgeryImaging doseFractionation schemeCyberKnife robotic radiosurgeryX-ray tubeDifferent fractionation schemesFlat-panel detectorEntrance skin exposureMedian numberStereotactic radiosurgerySkin exposureOperator adjustmentRadiosurgeryDoseKVPatientsSampling intervalCyberKnifeDose difference